Our lab has uncovered encouraging preliminary evidence that anti-HTRA1 single-chain variable fragment (scFv) can significantly reduce the size of neovascular lesions in a laser-induced mouse model of wet AMD[151]. This evidence concerns the gene HTRA1 and wet macular degeneration.